보관된 글 — US — techcrunch
Onepot AI raises $13M to help make chemical drug creation easier
Onepot AI, founded by Daniil Boiko and Andrei Tyrin, has raised $13M to innovate drug discovery by simplifying small-molecule synthesis. Their AI-driven lab, POT-1, aims to speed up the creation of chemical compounds, enabling more efficient drug testing amidst global supply chain challenges, particularly in the context of geopolitical tensions and competition with China.
핵심 정리
- Founders Boiko and Tyrin identified synthesis challenges in drug discovery that hinder promising ideas.
- Onepot AI has raised $13M, including pre-seed and seed funding led by Fifty Years.
- The technology reduces synthesis time from months to days, making drug discovery more efficient.
- The lab captures data during experiments to ensure reproducibility and enables AI to generate hypotheses.
- Future plans include expanding to a second lab and enhancing the compound discovery engine.
왜 중요한가
- Ongoing drug discovery struggles are compounded by geopolitical tensions, especially between the U.S. and China.
- Recent trends in AI and ML are making significant impacts across industries, particularly in R&D for pharmaceuticals.
- The innovation landscape in drug synthesis reflects broader tech advancements aiming to streamline complex processes in various fields.
Onepot AI aims to transform drug discovery with its AI-driven synthesis solutions, addressing critical challenges in the field while adapating to current geopolitical dynamics, ultimately accelerating the journey from concept to viable drugs.